Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ergolines as selective 5-HT1 agonists.

J S Ward1, R W Fuller, L Merritt

  • 1Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285.

Journal of Medicinal Chemistry
|August 1, 1988
PubMed
Summary

Researchers synthesized novel ergolines, identifying potent compounds selective for serotonin 5-HT1 receptors. These ergolines effectively modulated serotonin levels and increased corticosterone, indicating direct receptor stimulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurochemical effects of CM 57227 and CM 57373, two anorectic agents, on brain serotonin neurons in rats.

Neurochemistry international·2010
Same author

Evaluating daily exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in fish oil supplements.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2010
Same author

Structural relationships in the inhibition of [(3)H]serotonin binding to rat brain membranes in vitro by 1-phenyl-piperazines.

Biochemical pharmacology·2010
Same author

Phylogenetic studies on Corynebacterium bovis isolated from bovine mammary glands.

Journal of dairy science·2002
Same author

The stereochemical outcome of electrophilic addition reactions on the 5,6-double bond in the spinosyns.

The Journal of organic chemistry·2001
Same author

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.

The Journal of clinical investigation·2001

Area of Science:

  • Medicinal Chemistry
  • Neuropharmacology
  • Endocrinology

Background:

  • Ergolines are a class of compounds with diverse pharmacological activities.
  • Serotonin receptors, particularly the 5-HT1 subtype, are crucial targets for neurological and psychiatric disorders.
  • Understanding structure-activity relationships of ergolines is key to developing selective receptor modulators.

Purpose of the Study:

  • To synthesize and characterize a series of ergoline derivatives.
  • To evaluate their affinity and selectivity for serotonin receptor subtypes.
  • To investigate the in vivo effects of potent ergoline compounds on neurotransmitter turnover and hormonal levels.

Main Methods:

  • Synthesis of 8-substituted (3 beta, 5 beta)-9,10-didehydro-6-methylergolines.

Related Experiment Videos

  • Assessment of receptor binding affinity for various serotonin receptor subtypes.
  • Measurement of serotonin and 5-hydroxyindoleacetic acid (5-HIAA) levels in rat brain homogenates.
  • Determination of dopamine turnover in rat brain and striatum.
  • Evaluation of alpha-adrenergic binding site affinity.
  • Analysis of serum corticosterone concentrations in rats following compound administration.

    • Main Results:

    • Several 8-substituted ergolines demonstrated high selectivity for the serotonin 5-HT1 receptor subtype.
    • Potent compounds increased brain serotonin and decreased 5-HIAA, indicating reduced serotonin turnover.
    • Oral administration of ergoline 13 led to sustained decreases in serotonin turnover.
    • Compound 13 showed minimal dopaminergic activity and lower affinity for alpha-adrenergic sites compared to 5-HT1 sites.
    • Increased serum corticosterone levels induced by compound 13 were not affected by fluoxetine or p-chlorophenylalanine.

    Conclusions:

    • The synthesized ergolines exhibit promising selectivity for serotonin 5-HT1 receptors.
    • Compound 13, a 2,3-dihydrolysergine derivative, effectively modulates serotonin turnover.
    • The observed increase in corticosterone suggests that compound 13 directly stimulates serotonin receptors, independent of serotonin reuptake or synthesis inhibition.